Literature DB >> 6408038

Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: the role of adjuvant pre or postoperative radiation therapy.

G Kopelson.   

Abstract

From 1972 to 1981, 7 patients received adjuvant external beam radiation therapy before (5 patients) or after (2 patients) a curative Whipple operation for adenocarcinoma of the pancreas (5 patients) or ampulla of Vater (2 patients). Via supervoltage, 4000-4520 rad/20-25 fractions/4-5 1/2 weeks were delivered to the tumor bed and draining lymphatics. Two patients (of 4 at risk) are 5-year survivors; 3 are alive-without-disease at 1-2 years follow-up. Distant metastases have developed to date in 3 patients. A marginal miss occurred at the edge of radiation portal in 1 patient, and no true in-field failures have occurred. Complications occurred in 2 patients. Because of the high incidence of local-regional failures after curative surgery alone for adenocarcinoma of the pancreas or ampulla of Vater, the above results suggest that adjuvant radiation therapy should be considered as a modality to potentially improve treatment results.

Entities:  

Mesh:

Year:  1983        PMID: 6408038     DOI: 10.1016/0360-3016(83)90018-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  Current and emerging treatments for pancreatic cancer.

Authors:  W F Regine; W J John; M Mohiuddin
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.

Authors:  Michael D Chuong; Tom J Hayman; Manish R Patel; Mark S Russell; Mokenge P Malafa; Pamela J Hodul; Gregory M Springett; Junsung Choi; Ravi Shridhar; Sarah E Hoffe
Journal:  Gastrointest Cancer Res       Date:  2011-07

Review 3.  Adjuvant therapy for pancreatic cancer.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Amol K Narang; Robert C Miller; Charles C Hsu; Sumita Bhatia; Timothy M Pawlik; Dan Laheru; Ralph H Hruban; Jessica Zhou; Jordan M Winter; Michael G Haddock; John H Donohue; Richard D Schulick; Christopher L Wolfgang; John L Cameron; Joseph M Herman
Journal:  Radiat Oncol       Date:  2011-09-28       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.